ClinicalTrials.Veeva

Menu
Q

Quotient Sciences | Nottingham

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

anle138b
BMS-986165
BOS172767
Relugolix
FDL169
NM-101
DNDI-0690
GLPG3970
Trimethoprim
14C-NW-3509

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 60 total trials

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

The purpose of this study is to confirm there is no significant effect of gastric pH changes of famotidine on the drug levels of afimetoran in health...

Enrolling
Healthy Volunteers
Drug: Afimetoran
Drug: Famotidine

This is a two-part, single centre, double-blind (within cohorts), randomised, placebo-controlled, single (Part 1) and multiple (Part 2) ascending sub...

Enrolling
Overweight
Healthy Volunteers
Drug: GUB014295-PLACEBO
Drug: GUB014295

This is a Phase I, double-blind, randomised, two-part, single-ascending dose (Part 1) and multiple-ascending dose (Part 2) study of NM-101 in healthy...

Not yet enrolling
Parkinson Disease
Drug: NM-101
Drug: Placebo

The purpose of this study is to identify drug levels of gastro-retentive (GR) formulations which prolong retaining time in the stomach of deucravacit...

Enrolling
Healthy Participants
Drug: Deucravacitinib

Trial sponsors

Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
G
M
B
Boston Scientific logo
F
M
S
D

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems